Will we miss specific IgA detection for the diagnosis of congenital toxoplasmosis? A French retrospective monocenter study on 483 infants

To estimate the performance of anti-<i>Toxoplasma</i> IgA assay for the diagnosis of congenital toxoplasmosis, a retrospective monocenter study was conducted comparing serological results obtained in the framework of routine diagnosis workup. All infants born to mothers infected with <i>Toxoplasma gondii</i> during pregnancy from 2010 to 2023 with at least 6 months of serological follow-up were included. Four hundred and eighty-three cases (1,171 sera) were included, of which 56 infants (11.6%) were infected. Twenty out of 60 infants (33.3%) with positive IgA were not infected. The sensitivity to detect IgA antibodies in infected neonates was 71.4%. The specificity was 97.3%. The mean time to detect IgA was 7.7 ± 13.0 days in infected neonates. Anti-<i>Toxoplasma</i> IgA was the earliest positive serological test in only two cases (5.0%) but turned negative at 1 month in the absence of specific treatment, suggesting non-specific detection. IgA was associated with anti-<i>Toxoplasma</i> IgM, neosynthetized IgG or IgM on comparative Western blotting (WB), or both IgM and neosynthetized IgG or IgM on WB, in 12 cases (30.0%), 2 cases (5.0%), and 19 cases (47.5%), respectively. Sixteen infants with no IgA after birth were diagnosed via neosynthetized IgG or IgM on comparative WB and/or IgM (<i>n</i> = 10), or via PCR on amniotic fluid (<i>n</i> = 5), or persistent IgG (<i>n</i> = 1). Our study suggests that anti-<i>Toxoplasma</i> IgA is not a critical serological parameter for the diagnosis of congenital toxoplasmosis, and the recent withdrawal of commercialized reference anti-<i>Toxoplasma</i> IgA assays should not affect patient care.IMPORTANCEThis study will help clinical microbiologists estimate the impact of the withdrawal of anti-<i>Toxoplasma</i> IgA reference assays for the diagnosis of congenital toxoplasmosis and will contribute to actualize the recommendations for laboratory diagnosis.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Microbiology
Published
2025-08-11
DOI
https://doi.org/10.1128/jcm.00379-25
Primary Topic
Toxoplasma gondii Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Will we miss specific IgA detection for the diagnosis of congenital toxoplasmosis? A French retrospective monocenter study on 483 infants

Hélène Guegan, Jean‐Pierre Gangneux, Florence Robert-Gangneux, Sorya Belaz et al.
Journal of Clinical Microbiology
Toxoplasma gondii Research Studies
article

Will we miss specific IgA detection for the diagnosis of congenital toxoplasmosis? A French retrospective monocenter study on 483 infants

Hélène Guegan, Jean‐Pierre Gangneux, Florence Robert-Gangneux, Sorya Belaz, Lya Hamet
article en

Abstract

To estimate the performance of anti-<i>Toxoplasma</i> IgA assay for the diagnosis of congenital toxoplasmosis, a retrospective monocenter study was conducted comparing serological results obtained in the framework of routine diagnosis workup. All infants born to mothers infected with <i>Toxoplasma gondii</i> during pregnancy from 2010 to 2023 with at least 6 months of serological follow-up were included. Four hundred and eighty-three cases (1,171 sera) were included, of which 56 infants (11.6%) were infected. Twenty out of 60 infants (33.3%) with positive IgA were not infected. The sensitivity to detect IgA antibodies in infected neonates was 71.4%. The specificity was 97.3%. The mean time to detect IgA was 7.7 ± 13.0 days in infected neonates. Anti-<i>Toxoplasma</i> IgA was the earliest positive serological test in only two cases (5.0%) but turned negative at 1 month in the absence of specific treatment, suggesting non-specific detection. IgA was associated with anti-<i>Toxoplasma</i> IgM, neosynthetized IgG or IgM on comparative Western blotting (WB), or both IgM and neosynthetized IgG or IgM on WB, in 12 cases (30.0%), 2 cases (5.0%), and 19 cases (47.5%), respectively. Sixteen infants with no IgA after birth were diagnosed via neosynthetized IgG or IgM on comparative WB and/or IgM (<i>n</i> = 10), or via PCR on amniotic fluid (<i>n</i> = 5), or persistent IgG (<i>n</i> = 1). Our study suggests that anti-<i>Toxoplasma</i> IgA is not a critical serological parameter for the diagnosis of congenital toxoplasmosis, and the recent withdrawal of commercialized reference anti-<i>Toxoplasma</i> IgA assays should not affect patient care.IMPORTANCEThis study will help clinical microbiologists estimate the impact of the withdrawal of anti-<i>Toxoplasma</i> IgA reference assays for the diagnosis of congenital toxoplasmosis and will contribute to actualize the recommendations for laboratory diagnosis.

Journal of Clinical MicrobiologyVol. 63(9)
Inserm (FR), Institut de Recherche en Santé, Environnement et Travail (FR), Centre Hospitalier Universitaire de Rennes (FR), Université de Rennes (FR)
Good health and well-being
Openalex Percentile: Top 79%
Toxoplasma gondii Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.